Recent patents on cardiovascular stem cells

Area of Science:

• Regenerative Medicine
• Cardiovascular Science
• Biotechnology

Background:

• Chronic heart failure is a major global health burden.
• Replacing scar tissue with viable myocardium and enhancing neovascularization can improve cardiac function.
• Stem and progenitor cell therapies show promise for improving cardiac perfusion and contractility.

Purpose of the Study:

• To review patent applications for cell-based and non-cell-based therapies in regenerative cardiovascular medicine.
• To provide an overview of the current patent landscape in stem cell applications for cardiovascular diseases.
• To aid future decision-making in developing novel therapeutic strategies.

Main Methods:

• Systematic screening of patent databases.
• Categorization of patents into cell-based therapies, growth factor applications, angiogenesis/vascular function improvements, and stem cell differentiation methods.
• Review of patents related to generating cardiomyocytes from stem cells.

Main Results:

• Identified various patent applications for cell-based therapies and growth factors to enhance cardiovascular function.
• Cataloged patents focused on improving angiogenesis, re-endothelialization, and overall vascular function.
• Detailed patents concerning enhanced differentiation of stem cells into cardiovascular cells, including cardiomyocytes.

Conclusions:

• A comprehensive patent overview is crucial for advancing regenerative cardiovascular medicine.
• Understanding the patent landscape facilitates the development of novel therapeutic strategies.
• Stem cell-based approaches, including directed differentiation, are central to future cardiovascular regenerative therapies.